RCE. ai is a pioneering health tech company on a mission to save human lives through the early detection of heart injury. Each year, over 10 million individuals visit emergency departments (EDs) for chest pain, but only 1 out of 5 cases are cardiac-related.

To rule out non-cardiac causes, patients undergo a series of cardiac protein measurements, taking about 55 minutes each, leading to unnecessary hours of hospitalization. RCE. ai offers a breakthrough solution with non-invasive, instant measurement of cardiac proteins.

This improves patient outcomes by reducing hospital length of stay and associated healthcare costs. The company's cutting-edge technology has gained recognition in renowned publications such as Nature Reviews Cardiology and the Journal of the American Medical Association (JAMA). With a distinguished team of founders, optical scientists, clinical advisors, and scientific advisory board members, RCE.

ai is committed to connecting with patients, research collaborators, and industry partners to further their life-saving mission